Zota Health Care Limited (NSE:ZOTA)
India · Delayed Price · Currency is INR 1,118.80
+4.70 (0.42%)
Sep 17, 2026, 3:29 PM IST
Zota Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 6,087 | 5,387 | 2,930 | 1,805 | 1,400 | 1,312 |
Other Revenue | - | - | - | - | 7.94 | 0.77 |
| 6,087 | 5,387 | 2,930 | 1,805 | 1,408 | 1,313 | |
Revenue Growth | 78.89% | 83.86% | 62.32% | 28.23% | 7.22% | 22.47% |
Cost of Revenue | 2,349 | 2,147 | 1,385 | 971.65 | 835.11 | 867.29 |
Gross Profit | 3,738 | 3,239 | 1,545 | 833.24 | 572.41 | 445.41 |
Selling, General & Admin | 2,063 | 2,057 | 998.59 | 371.74 | 212.65 | 159.4 |
Other Operating Expenses | 1,645 | 994.01 | 593.72 | 385.95 | 278.46 | 137.26 |
Operating Expenses | 4,663 | 3,876 | 2,024 | 958.55 | 610.68 | 333.37 |
Operating Income | -925.37 | -636.55 | -479.32 | -125.31 | -38.27 | 112.05 |
Interest Expense | -204.75 | -144.53 | -89.74 | -41.99 | -24.86 | -2.58 |
Interest & Investment Income | - | 63.2 | 17.09 | 9.37 | 8.82 | 13.16 |
Currency Exchange Gain (Loss) | - | 10.92 | 2.56 | 1.94 | 2.37 | 2.3 |
Other Non Operating Income (Expenses) | 86.05 | -28.83 | -17.06 | -5.64 | -0.36 | -0.58 |
EBT Excluding Unusual Items | -1,044 | -735.78 | -566.48 | -161.63 | -52.29 | 124.35 |
Merger & Restructuring Charges | - | - | -7.81 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | -0.08 | - | - | - |
Other Unusual Items | -60 | -62.59 | -2.07 | - | 5.38 | - |
Pretax Income | -1,104 | -798.37 | -576.44 | -161.63 | -46.91 | 124.35 |
Income Tax Expense | -61.62 | -57.59 | -9.06 | -18.15 | 10.82 | 35.27 |
Earnings From Continuing Operations | -1,042 | -740.77 | -567.39 | -143.48 | -57.73 | 89.08 |
Minority Interest in Earnings | 10.69 | 1.41 | 3.41 | - | - | - |
Net Income | -1,032 | -739.36 | -563.98 | -143.48 | -57.73 | 89.08 |
Net Income to Common | -1,032 | -739.36 | -563.98 | -143.48 | -57.73 | 89.08 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 34 | 33 | 27 | 26 | 25 | 25 |
Shares Outstanding (Diluted) | 34 | 33 | 27 | 26 | 25 | 25 |
Shares Change | 22.87% | 20.71% | 6.33% | 1.93% | 1.11% | 1.32% |
EPS (Basic) | -30.08 | -22.46 | -20.68 | -5.59 | -2.29 | 3.58 |
EPS (Diluted) | -30.08 | -22.46 | -20.68 | -5.59 | -2.29 | 3.58 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -2,083 | -959.42 | -226.94 | -145.05 | 100.84 |
Free Cash Flow Per Share | - | -63.27 | -35.18 | -8.85 | -5.76 | 4.05 |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | 1.000 | 1.500 |
Dividend Growth | - | 0% | 0% | 0% | -33.33% | 50.00% |
Gross Margin | 61.41% | 60.14% | 52.73% | 46.17% | 40.67% | 33.93% |
Operating Margin | -15.20% | -11.82% | -16.36% | -6.94% | -2.72% | 8.54% |
Profit Margin | -16.95% | -13.73% | -19.25% | -7.95% | -4.10% | 6.79% |
Free Cash Flow Margin | - | -38.67% | -32.75% | -12.57% | -10.31% | 7.68% |
EBITDA | 69.5 | -313.95 | -336.18 | -63.1 | 2.83 | 140.75 |
EBITDA Margin | 1.14% | -5.83% | -11.47% | -3.50% | 0.20% | 10.72% |
D&A For EBITDA | 994.88 | 322.59 | 143.15 | 62.21 | 41.1 | 28.7 |
EBIT | -925.37 | -636.55 | -479.32 | -125.31 | -38.27 | 112.05 |
EBIT Margin | -15.20% | -11.82% | -16.36% | -6.94% | -2.72% | 8.54% |
Effective Tax Rate | - | - | - | - | - | 28.37% |
Revenue as Reported | 6,173 | 5,461 | 2,950 | 1,816 | 1,419 | 1,328 |
Advertising Expenses | - | 247.18 | 121.52 | 62.27 | 78.95 | 50.1 |